Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 35.92
+1.59 (4.63%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 5,256 | 5,528 | 3,452 | 3,229 | 4,928 | 7,456 | Upgrade
|
| Market Cap Growth | 27.31% | 60.13% | 6.92% | -34.48% | -33.91% | - | Upgrade
|
| Enterprise Value | 3,857 | 4,006 | 1,845 | 1,370 | 2,774 | 5,736 | Upgrade
|
| Last Close Price | 35.92 | 37.78 | 22.73 | 20.21 | 28.71 | 41.65 | Upgrade
|
| PE Ratio | 171.74 | 112.24 | 20.36 | 30.29 | 6.37 | 8.94 | Upgrade
|
| PS Ratio | 11.69 | 12.34 | 6.17 | 7.30 | 2.59 | 4.10 | Upgrade
|
| PB Ratio | 2.22 | 2.33 | 1.43 | 1.33 | 1.92 | 3.54 | Upgrade
|
| P/TBV Ratio | 2.51 | 2.63 | 1.62 | 1.46 | 2.10 | 3.57 | Upgrade
|
| P/FCF Ratio | - | - | - | 43.08 | 9.40 | 10.53 | Upgrade
|
| P/OCF Ratio | 86.29 | 51.92 | 26.80 | 24.58 | 7.01 | 8.21 | Upgrade
|
| EV/Sales Ratio | 8.58 | 8.94 | 3.30 | 3.10 | 1.46 | 3.16 | Upgrade
|
| EV/EBITDA Ratio | 63.81 | 66.60 | 13.77 | 47.44 | 3.59 | 5.92 | Upgrade
|
| EV/EBIT Ratio | 108.89 | 111.63 | 16.36 | 325.74 | 3.69 | 5.97 | Upgrade
|
| EV/FCF Ratio | -47.30 | - | - | 18.28 | 5.29 | 8.10 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.00 | 0.09 | 0.01 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.04 | 0.02 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.59 | -0.63 | -0.68 | -0.79 | -0.79 | -0.81 | Upgrade
|
| Net Debt / EBITDA Ratio | -23.21 | -24.75 | -12.32 | -66.28 | -2.63 | -1.77 | Upgrade
|
| Net Debt / FCF Ratio | 17.21 | 63.62 | 14.20 | -25.54 | -3.88 | -2.42 | Upgrade
|
| Asset Turnover | 0.18 | 0.17 | 0.22 | 0.17 | 0.73 | 1.19 | Upgrade
|
| Inventory Turnover | 3.29 | 3.38 | 3.32 | 2.30 | 6.79 | 6.03 | Upgrade
|
| Quick Ratio | 13.33 | 10.02 | 9.81 | 13.27 | 12.16 | 5.93 | Upgrade
|
| Current Ratio | 14.11 | 10.52 | 10.51 | 13.97 | 13.07 | 6.40 | Upgrade
|
| Return on Equity (ROE) | 1.21% | 1.97% | 6.90% | 4.23% | 33.13% | 65.52% | Upgrade
|
| Return on Assets (ROA) | 0.88% | 0.87% | 2.72% | 0.10% | 18.15% | 39.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.84% | 4.14% | 15.22% | 0.74% | 140.06% | 283.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.50% | 1.50% | 4.70% | 0.20% | 29.20% | 45.50% | Upgrade
|
| Earnings Yield | 0.58% | 0.89% | 4.91% | 3.30% | 15.70% | 11.18% | Upgrade
|
| FCF Yield | -1.55% | -0.42% | -3.37% | 2.32% | 10.64% | 9.50% | Upgrade
|
| Dividend Yield | 3.12% | - | 4.71% | 2.83% | 5.47% | 5.15% | Upgrade
|
| Payout Ratio | 351.88% | 324.60% | 49.34% | 220.13% | 41.37% | 2.51% | Upgrade
|
| Buyback Yield / Dilution | 1.59% | 1.72% | 1.23% | 0.10% | -23.14% | -8.33% | Upgrade
|
| Total Shareholder Return | 4.72% | 1.72% | 5.95% | 2.93% | -17.67% | -3.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.